About Desmin
Desmin (DES) is a protein
from Homo sapiens identified by UniProt accession
P17661, 470 residues long.
MolForge cross-references it against 0 known binders and
1,097 disease associations.
Target properties
| Protein name | Desmin |
| UniProt accession | P17661 |
| Gene | DES |
| Organism | Homo sapiens |
| Length | 470 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1097)
Diseases linked to this target (Open Targets).
- Desminopathy · score 0.85
- myofibrillar myopathy 1 · score 0.83
- dilated cardiomyopathy 1I · score 0.78
- neurogenic scapuloperoneal syndrome, Kaeser type · score 0.71
- Scapuloperoneal amyotrophy · score 0.70
- Autosomal recessive limb-girdle muscular dystrophy due to desmin deficiency · score 0.67
- dilated cardiomyopathy · score 0.65
- myofibrillar myopathy · score 0.64
- cardiomyopathy · score 0.58
- arrhythmogenic right ventricular cardiomyopathy · score 0.50
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P17661-F1 | alphafold | PREDICTED | 76.55 | — |
Amino-acid sequence (470 residues)
MSQAYSSSQR VSSYRRTFGG APGFPLGSPL SSPVFPRAGF GSKGSSSSVT SRVYQVSRTS GGAGGLGSLR ASRLGTTRTP SSYGAGELLD FSLADAVNQE FLTTRTNEKV ELQELNDRFA NYIEKVRFLE QQNAALAAEV NRLKGREPTR VAELYEEELR ELRRQVEVLT NQRARVDVER DNLLDDLQRL KAKLQEEIQL KEEAENNLAA FRADVDAATL ARIDLERRIE SLNEEIAFLK KVHEEEIREL QAQLQEQQVQ VEMDMSKPDL TAALRDIRAQ YETIAAKNIS EAEEWYKSKV SDLTQAANKN NDALRQAKQE MMEYRHQIQS YTCEIDALKG TNDSLMRQMR ELEDRFASEA SGYQDNIARL EEEIRHLKDE MARHLREYQD LLNVKMALDV EIATYRKLLE GEESRINLPI QTYSALNFRE TSPEQRGSEV HTKKTVMIKT IETRDGEVVS EATQQQHEVL
Explore Desmin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets